Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data
about
Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysisNon-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands.Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.
P2860
Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@ast
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@en
type
label
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@ast
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@en
prefLabel
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@ast
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@en
P2093
P2860
P921
P1433
P1476
Cost-Effectiveness of Dabigatr ...... herlands Using Real-World Data
@en
P2093
Frank G Jansman
Jacobus R B J Brouwers
Jelena Stevanović
Maarten J Beinema
Maarten J Postma
Merlijn W J van Leent
P2860
P304
P356
10.1371/JOURNAL.PONE.0135054
P407
P577
2015-08-04T00:00:00Z